Publications by authors named "Beatrix Versmold"

Claim this Profile
F
First international workshop of the ATM and cancer risk group (4-5 December 2019).
Fabienne Lesueur, Douglas F Easton, Anne-Laure Renault, Sean V Tavtigian, Jonine L Bernstein, Beatrix Versmold

Fam Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer.
Jan Hauke, Judit Horvath, Eva Groß, Andrea Gehrig, Ellen Honisch, Beatrix Versmold

Cancer Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of death receptor 4 variant (683A > C) with ovarian cancer risk in BRCA1 mutation carriers.
Michelle G Dick, Beatrix Versmold, Christoph Engel, Alfons Meindl, Norbert Arnold

Int J Cancer· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Christoph Engel, Beatrix Versmold, Barbara Wappenschmidt, Jacques Simard, Douglas F Easton

Cancer Epidemiol Biomarkers Prev· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.
Antonis C Antoniou, Olga M Sinilnikova, Lesley McGuffog, Sue Healey, Heli Nevanlinna, Beatrix Versmold

Hum Mol Genet· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study.
Timothy R Rebbeck, Antonis C Antoniou, Trinidad Caldes Llopis, Heli Nevanlinna, Kristiina Aittomäki, Beatrix Versmold

Breast Cancer Res Treat· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corticosteroids reverse cytokine-induced block of survival and differentiation of oligodendrocyte progenitor cells from rats.
Stefan A Mann, Beatrix Versmold, Romy Marx, Sabine Stahlhofen, Irmgard D Dietzel

J Neuroinflammation· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Antonis C Antoniou, Amanda B Spurdle, Olga M Sinilnikova, Sue Healey, Karen A Pooley, Beatrix Versmold

Am J Hum Genet· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.
Antonis C Antoniou, Olga M Sinilnikova, Jacques Simard, Mélanie Léoné, Martine Dumont, Beatrix Versmold

Am J Hum Genet· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer.
Beatrix Versmold, Jörg Felsberg, Thomas Mikeska, Denise Ehrentraut, Juliane Köhler

Int J Cancer· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study.
Fergus J Couch, Olga Sinilnikova, Robert A Vierkant, V Shane Pankratz, Zachary S Fredericksen, Beatrix Versmold

Cancer Epidemiol Biomarkers Prev· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis